Cited by 5

The DOI matches its Crossref record.

Bone morphogenetic protein signaling: a promising target for white matter protection in perinatal brain injury

Dizon, MariaL.V., Chang, Jill, Dettman, RobertW·2018·Neural Regeneration Research

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.4103/1673-5374.235025

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

No references could be resolved yet.

Research works printed but not linked: 13

  1. Dettman RW, Birch D, Fernando A, Kessler JA, Dizon MLV (2018) Targeted knockdown of bone morphogenetic protein signaling within neural progenitors protects the brain and improves motor function following postnatal hypoxia-ischemia. Dev Neurosci 40:23-38. · DOI
  2. Dizon ML, Maa T, Kessler JA (2011) The bone morphogenetic protein antagonist noggin protects white matter after perinatal hypoxia-ischemia. Neurobiol Dis 42:318-326. · DOI
  3. Dummula K, Vinukonda G, Chu P, Xing Y, Hu F, Mailk S, Csiszar A, Chua C, Mouton P, Kayton RJ, Brumberg JC, Bansal R, Ballabh P (2011) Bone morphogenetic protein inhibition promotes neurological recovery after intraventricular hemorrhage. J Neurosci 31:12068-12082. · DOI
  4. Fukuda S, Abematsu M, Mori H, Yanagisawa M, Kagawa T, Nakashima K, Yoshimura A, Taga T (2007) Potentiation of astrogliogenesis by STAT3-mediated activation of bone morphogenetic protein-smad signaling in neural stem cells. Mol Cell Biol 27:4931-4937. · DOI
  5. Fung C, Brown A, Cox J, Callaway C, McKnight R, Lane R (2011) Novel thromboxane A2 analog-induced IUGR mouse model. J Dev Orig Health Dis 2:291-301. · DOI
  6. Furuta Y, Piston DW, Hogan BL (1997) Bone morphogenetic proteins (BMPs) as regulators of dorsal forebrain development. Development 124:2203-2212. · DOI
  7. Gomes WA, Mehler MF, Kessler JA (2003) Transgenic overexpression of BMP4 increases astroglial and decreases oligodendroglial lineage commitment. Dev Biol 255:164-177. · DOI
  8. Lehman LL, Rivkin MJ (2014) Perinatal arterial ischemic stroke: presentation, risk factors, evaluation, and outcome. Pediatr Neurol 51:760-768. · DOI
  9. Levine TA, Grunau RE, McAuliffe FM, Pinnamaneni R, Foran A, Alderdice FA (2015) Early childhood neurodevelopment after intrauterine growth restriction: a systematic review. Pediatrics 135:126-141. · DOI
  10. Natarajan G, Shankaran S, Pappas A, Bann C, Tyson JE, McDonald S, Das A, Hintz S, Vohr B, Higgins R; Extended Hypothermia Subcommittee of the Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network (2014) Functional status at 18 months of age as a predictor of childhood disability after neonatal hypoxic-ischemic encephalopathy. Dev Med Child Neurol 56:1052-1058. · DOI
  11. Petersen MA, Ryu JK, Chang KJ, Etxeberria A, Bardehle S, Mendiola AS, Kamau-Devers W, Fancy SPJ, Thor A, Bushong EA, Baeza-Raja B, Syme CA, Wu MD, Rios Coronado PE, Meyer-Franke A, Yahn S, Pous L, Lee JK, Schachtrup C, Lassmann H, et al. (2017) Fibrinogen activates BMP signaling in oligodendrocyte progenitor cells and inhibits remyelination after vascular damage. Neuron 96:1003-1012.e7. · DOI
  12. Reid MV, Murray KA, Marsh ED, Golden JA, Simmons RA, Grinspan JB (2012) Delayed myelination in an intrauterine growth retardation model is mediated by oxidative stress upregulating bone morphogenetic protein 4. J Neuropathol Exp Neurol 71:640-653. · DOI
  13. Rysavy MA, Li L, Bell EF, Das A, Hintz SR, Stoll BJ, Vohr BR, Carlo WA, Shankaran S, Walsh MC, Tyson JE, Cotten CM, Smith PB, Murray JC, Colaizy TT, Brumbaugh JE, Higgins RD; Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network (2015) Between-hospital variation in treatment and outcomes in extremely preterm infants. N Engl J Med 372:1801-1811. · DOI

Cited by

Sorted by citations

Metadata

Authors
Dizon, M. V., Chang, J., & Dettman, R.
Venue
Neural Regeneration Research
Published
2018
Volume
13
Issue
7
Pages
1183
ISSN
1673-5374
Cited by
5
References
0
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review